Q5103
HCPCSInjection, inflectra
Official HCPCS Level II long descriptor
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
HCPCS Level II code Q5103 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Injection, inflectra
Added to HCPCS: 2018-04-01
Nearby codes in Q5
- Q5007Hospice in ltch
- Q5008Hospice in inpatient psych
- Q5009Hospice/home hlth, place nos
- Q5010Hospice home care in hospice
- Q5098Inj ustekinumab-srlf, 1 mg
- Q5099Inj ustekinumab-stba, 1 mg
- Q5100Inj ustekinumab-kfce, 1 mg
- Q5101Injection, zarxio
- Q5104Injection, renflexis
- Q5105Inj retacrit esrd on dialysi
- Q5106Inj retacrit non-esrd use
- Q5107Inj mvasi 10 mg
- Q5108Injection, fulphila
- Q5110Nivestym
- Q5111Injection, udenyca 0.5 mg
- Q5112Inj ontruzant 10 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.